References
- Culyer AJ. A glossary of the more common terms encountered in health economics. In: Hersh-Cochran MS, Cochran KP, editors. Compendium of English language course syllabi and textbooks in health economics. Copenhagen: world Health Organization; 1989. pp. 215–234.
- Mendoza RL. Continuity and change in the drug supply chain: actors, actions, and aversions. J Med Econ. 2021;24(1):689–697. doi:10.1080/13696998.2021.1925123.
- Obermann K, Thielscher C. Medical economics: an integrated approach to the economics of health. Newcastle upon Tyne: Agenda Publishing; 2022.
- Annual meetings of the American Economic Association (AEA), in conjunction with 64 associations in economics-related disciplines that form the Allied Social Science Association (ASSA). New Orleans, Louisiana, 2023 Jan 6–8.
- Congressional Budget Office (CBO). Research and development in the pharmaceutical industry. Washington (DC): CBO; 2021. Available from: https://www.cbo.gov/publication/57126.
- Mendoza RL. The 21st century cures act: pharmacoeconomic boon or bane? J Med Econ. 2017;20(4):315–317. doi:10.1080/13696998.2017.1282865.
- Michelman V, Msall L. Sex, drugs, and R&D: missing innovation from regulating female enrollment in clinical trials. Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 8.
- Gupta H. Do female researchers increase female enrollment in clinical trials? Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 8.
- Pairoleroa NA, Toole AA, Pappas PA, et al. Closing the gender gap in patenting: evidence from a randomized control trial at the USPTO. Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 8.
- Alsan M, Durvasula M, Gupta H, et al. Representation and extrapolation: evidence from clinical trials. Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 8.
- Aghamolla C, Karaca-Mandic P, Li X, et al. Merchants of death: the effect of credit supply shocks on hospital outcomes. Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 6.
- Gao J, Kim Y, Sevilir M. Private equity in the hospital industry. Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 6.
- Cramer KF. Bank presence and health. Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 6.
- Lee RS, Ho K. Contracting over rebates: formulary design and pharmaceutical spending. Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 7.
- Hakobyan S, Rawlings H, Yao J. Equitable access to vaccines: myth or reality? Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 7.
- U.S. Food and Drug Administration (FDA). Vaccine development – 101. Silver Spring (MD): FDA; 2023. Available from: https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/vaccine-development-101.
- Azadfard M, Huecker MR, Leaming JM. Opioid addiction. In: statPearls [internet]. Treasure Island, FL: statPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448203/.
- Maclean JC, Mallatt J, Ruhm CJ, et al. The opioid crisis, health, healthcare, and crime: a review of quasi-experimental economic studies. Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 7.
- Peet E. Pharmaceutical innovations to fight the opioid crisis: evidence from the introduction of Narcan. Paper presented at the 2023 annual meetings of the Allied Social Sciences Association (ASSA); 2023 Jan 7.
- Burns LR. The U.S. healthcare ecosystem: payers, providers, producers. New York (NY): McGraw Hill; 2021.
- Newton I. Philosophiae naturalis principia mathematica. 1st ed. London: The Royal Society; 1687.